Europe — EMA

Novopulmon Novolizer (Budesonide)

Budesonide, the active ingredient in Novopulmon Novolizer, is a corticosteroid presented as a inhalation powder for oral inhalation use.

Budesonide

Request sourcing

Pack/s

What is Budesonide?

Budesonide, the active ingredient in Novopulmon Novolizer, is a corticosteroid presented as a inhalation powder for oral inhalation use. It treats asthma and chronic obstructive pulmonary disease (COPD) by reducing airway inflammation in adult patients. GNH USA supplies Novopulmon Novolizer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Novopulmon Novolizer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Budesonide used for?

Novopulmon Novolizer, a buddles ... - Asthma: Improves ... - COPD ... ...

What are the side effects of Budesonide?

Common ... - ...

What precautions apply to Budesonide?

The ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →